Skip to Content

Join the 'Familial Mediterranean Fever' group to help and get support from people like you.

Familial Mediterranean Fever News

FDA Approves Expanded Indications for Ilaris (canakinumab) for Three Rare Periodic Fever Syndromes

Posted 26 Sep 2016 by

September 23, 2016 – The U.S. Food and Drug Administration today approved three new indications for Ilaris (canakinumab). The new indications are for rare and serious auto-inflammatory diseases in adult and pediatric patients: Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS); Hyperimmunoglobulin D Syndrome (HIDS)/Mevalonate Kinase Deficiency (MKD); and Familial Mediterranean ...

Ask a Question

Further Information

Related Condition Support Groups

Periodic Fever Syndrome

Related Drug Support Groups

colchicine, Colcrys, Ilaris, canakinumab